Search research articles
Contact Us
Filters
Showing results (31-40 of 155) with videos related to
Page
of 16
Sort By:
Journal of Psychoactive Drugs
|
April 1, 1994
Evaluation and treatment of mood and anxiety disorders in opioid-dependent patients
E V Nunes, S J Donovan, R Brady, et al.
Psychopharmacology Bulletin
|
January 1, 1987
Treatment of tricyclic refractory depression with a monoamine oxidase inhibitor antidepressant
P J McGrath, J W Stewart, W Harrison, et al.
The American Journal of Psychiatry
|
May 1, 1991
Imipramine treatment of methadone maintenance patients with affective disorder and illicit drug use
E V Nunes, F M Quitkin, R Brady, et al.
Journal of the American Medical Women'S Association (1972)
|
November 1, 1991
Treatment of premenstrual dysphoric symptoms in depressed women
R Glick, W Harrison, J Endicott, et al.
Psychiatry Research
|
August 1, 1988
Tyramine sulfate excretion may be a better predictor of antidepressant response than monoamine oxidase activity
J W Stewart, W Harrison, T B Cooper, et al.
Comprehensive Psychiatry
|
May 1, 1993
How symptomatic do depressed patients remain after benefiting from medication treatment?
V Agosti, J W Stewart, F M Quitkin, et al.
Psychiatry Research
|
November 1, 1988
Effects of imipramine and phenelzine on plasma PEA levels
P J McGrath, T B Cooper, F M Quitkin, et al.
The American Journal of Psychiatry
|
August 2, 2001
Classifying depression
F M Quitkin, J W Stewart, P J McGrath, et al.
Psychiatry Research
|
August 1, 1990
Is seasonal affective disorder a variant of atypical depression? Differential response to light therapy
J W Stewart, F M Quitkin, M Terman, et al.
International Clinical Psychopharmacology
|
November 1, 2002
Somatization as a predictor of medication discontinuation due to adverse events
V Agosti, F M Quitkin, J W Stewart, et al.
Page
of 16
Search research articles
Search
Showing results (31-40 of 155) with videos related to
Sort By:
Page
of 16
Journal of Psychoactive Drugs
|
April 1, 1994
Evaluation and treatment of mood and anxiety disorders in opioid-dependent patients
E V Nunes, S J Donovan, R Brady, et al.
Psychopharmacology Bulletin
|
January 1, 1987
Treatment of tricyclic refractory depression with a monoamine oxidase inhibitor antidepressant
P J McGrath, J W Stewart, W Harrison, et al.
The American Journal of Psychiatry
|
May 1, 1991
Imipramine treatment of methadone maintenance patients with affective disorder and illicit drug use
E V Nunes, F M Quitkin, R Brady, et al.
Journal of the American Medical Women'S Association (1972)
|
November 1, 1991
Treatment of premenstrual dysphoric symptoms in depressed women
R Glick, W Harrison, J Endicott, et al.
Psychiatry Research
|
August 1, 1988
Tyramine sulfate excretion may be a better predictor of antidepressant response than monoamine oxidase activity
J W Stewart, W Harrison, T B Cooper, et al.
Comprehensive Psychiatry
|
May 1, 1993
How symptomatic do depressed patients remain after benefiting from medication treatment?
V Agosti, J W Stewart, F M Quitkin, et al.
Psychiatry Research
|
November 1, 1988
Effects of imipramine and phenelzine on plasma PEA levels
P J McGrath, T B Cooper, F M Quitkin, et al.
The American Journal of Psychiatry
|
August 2, 2001
Classifying depression
F M Quitkin, J W Stewart, P J McGrath, et al.
Psychiatry Research
|
August 1, 1990
Is seasonal affective disorder a variant of atypical depression? Differential response to light therapy
J W Stewart, F M Quitkin, M Terman, et al.
International Clinical Psychopharmacology
|
November 1, 2002
Somatization as a predictor of medication discontinuation due to adverse events
V Agosti, F M Quitkin, J W Stewart, et al.
Page
of 16